BioRestorative Therapies (BRTX) EBITDA Margin (2012 - 2026)
BioRestorative Therapies' EBITDA Margin came in at -14386.44% for Q1 2026, up 4636.57 percentage points from -19023.01% a year earlier and up 4860.82 percentage points from the prior quarter.
BioRestorative Therapies (BRTX) EBITDA Margin (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 31, 2026, BioRestorative Therapies reported EBITDA Margin of -3916.15%, down 832.94 percentage points year-over-year; for FY2025, it was -4291.67%, down 1457.22 percentage points from FY2024.
- EBITDA Margin carries a five-year change of -2535.07 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -2834.45% in FY2024 (+7491.37 pp), -10325.82% in FY2023 (+5411.65 pp), -15737.46% in FY2022 (+38795.64 pp) and -54533.10% in FY2021 (-52776.49 pp).
- The five-year range for quarterly EBITDA Margin is -125678.65% (Q4 2022) to -958.36% (Q3 2024).
- Year-over-year, EBITDA Margin increased in five of the last eight quarters, with an average year-over-year change of -2858.15 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q4 2023 (a gain of 109212.49 percentage points), and the weakest in Q4 2021 (a drop of 74822.72 percentage points).
- Business Quant data shows BRTX's EBITDA Margin at -19247.27% (Q4 2025), -30986.36% (Q3 2025) and -1072.38% (Q2 2025) in the three quarters before Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | BioRestorative Therapies | 1.36 Mn | -17.06 Mn | 15,785.00 | -14,386.44% |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -14,386.44% |
| Dec 31, 2025 | -18,894.89% |
| Sep 30, 2025 | -30,986.36% |
| Jun 30, 2025 | -1,072.38% |
| Mar 31, 2025 | -18,428.22% |
| Dec 31, 2024 | -6,096.47% |
| Sep 30, 2024 | -958.36% |
| Jun 30, 2024 | -2,717.29% |
| Mar 31, 2024 | -11,618.68% |
| Dec 31, 2023 | -16,466.16% |
| Sep 30, 2023 | -9,974.91% |
| Jun 30, 2023 | -4,767.48% |
| Mar 31, 2023 | -18,337.85% |
| Dec 31, 2022 | -125,678.65% |
| Sep 30, 2022 | -15,787.84% |
| Jun 30, 2022 | -6,465.70% |
| Mar 31, 2022 | -31,423.64% |
| Dec 31, 2021 | -78,454.60% |
| Sep 30, 2021 | -41,764.33% |
| Jun 30, 2021 | -21,387.03% |
BioRestorative Therapies EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();